Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
neratinib
×
Thoracic
×
Clear all
Filters
3
NCT01953926
2024-03-12
SUMMIT
Puma Biotechnology, Inc.
Phase 2
Terminated
582 enrolled
27 charts